Skip to content

Randomised controlled trial of standard EndoVenous Laser Ablation (EVLA) versus standard EVLA with below-knee foam sclerotherapy versus above and below-knee EVLA for varicose veins

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN31316759
Enrollment
69
Registered
2007-07-26
Start date
2005-11-10
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicose veins Circulatory System Diseases of the veins

Interventions

Two modified techniques are compared with standard EVLA technique: Group A: the standard practice of EVLA (laser ablation of above-knee Great Saphenous Vein [GSV]) considered as control Group B: modi

Sponsors

Leeds General Infirmary (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with primary varicose veins in the leg due to isolated incompetent sapheno-femoral junction and great saphenous vein reflux both above and below knee segments.

Exclusion criteria

Exclusion criteria: 1. Recurrent varicose veins 2. Patients with reflux in other axial veins 3. Patients with varicose veins only in thigh 4. Patients who has no reflux in below-knee segment of great saphenous vein

Design outcomes

Primary

MeasureTime frame
Sclerotherapy requirement at follow up: disease specific quality of life improvement measured by Aberdeen varicose vein severity score.

Secondary

MeasureTime frame
1. Post-procedure pain: patient analgesia diary 2. Cosmesis: as scored by the patient 3. Complication rates: wound infection, haematoma, nerve injury, DVT 4. Patient satisfaction

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026